Abstract:Glucagon-secreting pancreatic a-cells play pivotal roles in the development of diabetes. Glucagon promotes insulin secretion from I3-cells. However, the long-term effect of glucagon on the function and phenotype of I3-cells had remained elusive. In this study, we found that long-term glucagon intervention or glucagon intervention with the presence of palmitic acid downregulated I3-cell-specific markers and inhibited insulin secretion in cultured I3-cells. These results suggested that glucagon induced I3-cell dedifferentiation under pathological conditions. Glucagon blockage by a glucagon receptor (GCGR) monoclonal antibody (mAb) attenuated glucagon-induced I3-cell dedifferentiation. In primary islets, GCGR mAb treatment upregulated I3-cell-specific markers and increased insulin content, suggesting that blockage of endogenous glucagon-GCGR signaling inhibited I3-cell dedifferentia-tion. To investigate the possible mechanism, we found that glucagon decreased FoxO1 expression. FoxO1 inhibitor mimicked the effect of glucagon, whereas FoxO1 overexpression reversed the glucagon-induced I3-cell dedifferentiation. In db/db mice and I3-cell lineage-tracing diabetic mice, GCGR mAb lowered glucose level, upregulated plasma insulin level, increased I3-cell area, and inhibited I3-cell dedifferentiation. In aged I3-cell-specific FoxO1 knockout mice (with the blood glucose level elevated as a dia-betic model), the glucose-lowering effect of GCGR mAb was attenuated and the plasma insulin level, I3-cell area, and I3-cell dedif-ferentiation were not affected by GCGR mAb. Our results proved that glucagon induced I3-cell dedifferentiation under pathological conditions, and the effect was partially mediated by FoxO1. Our study reveals a novel cross talk between a- and I3-cells and is helpful to understand the pathophysiology of diabetes and discover new targets for diabetes treatment.NEW & NOTEWORTHY Glucagon-secreting pancreatic a-cells can interact with I3-cells. However, the long-term effect of gluca-gon on the function and phenotype of I3-cells has remained elusive. Our new finding shows that long-term glucagon induces I3-cell dedifferentiation in cultured I3-cells. FoxO1 inhibitor mimicks whereas glucagon signaling blockage by GCGR mAb reverses the effect of glucagon. In type 2 diabetic mice, GCGR mAb increases I3-cell area, improves I3-cell function, and inhibits I3-cell de-differentiation, and the effect is partially mediated by FoxO1.

3-Deoxyglucosone Interferes with Insulin Signaling and Attenuates Insulin Action on Glucose-Induced GLP-1 Secretion in the Enteroendocrine L Cell Line STC-1.

Acute Reduction of Incretin Effect and Glucose Intolerance in Rats by Single Intragastric Administration of 3-deoxyglucosone.

Accumulation of intestinal tissue 3-deoxyglucosone attenuated GLP-1 secretion and its insulinotropic effect in rats

Alteration of Intestinal Microbiota in 3-Deoxyglucosone-induced Prediabetic Rats.

Histone Deacetylase 3-Selective Inhibitor RGFP966 Ameliorates Impaired Glucose Tolerance Through Β-Cell Protection.

Improved post-prandial ghrelin response by nateglinide or acarbose therapy contributes to glucose stability in Type 2 diabetic patients

Glucagon receptor blockage inhibits ?-cell dedifferentiation through FoxO1

The Effects of Different Concentrations of Glucose on Glucose Sensors and GLP-1 Secretion in the Enteroendocrine Cell Line STC-1.

GdCl3 Reduces Hyperglycaemia Through Akt/FoxO1-induced Suppression of Hepatic Gluconeogenesis in Type 2 Diabetic Mice

Impact of glucotoxicity on TC1-6 cell glucagon secretion

GLP-1 Amplifies Insulin Signaling by Up-Regulation of IRβ, IRS-1 and Glut4 in 3T3-L1 Adipocytes

Glucagon-Like Skin-1’s Effect on Islet β Cells in High Glucose via AMPK/mTOR Pathway

Berberine Promotes Glucose Uptake and Inhibits Gluconeogenesis by Inhibiting Deacetylase SIRT3

3-Iodothyronamine reduces insulin secretion in vitro via a mitochondrial mechanism

Pharmacological Effects of EGLP-1, a Novel Analog of Glucagon-Like Peptide-1, on Carbohydrate and Lipid Metabolism

Effects of 2-Deoxy-D-Glucose on Insulin-Secretory Responses to Intravenous Glucose, Glucagon, Tolbutamide and Arginine in Man

Long Non-Coding RNA MEG 3 Mediates High Glucose-Induced Endothelial Cell Dysfunction

Ghrelin Regulates the Proliferation and Apoptosis of High Glucose‐induced Islet Cells Through the PI3K–Akt Signaling Pathway

Anti-CD3 Antibody Treatment Induces Hypoglycemia and Super Tolerance to Glucose Challenge in Mice through Enhancing Glucose Consumption by Activated Lymphocytes

Increasing Glucagon Secretion Could Antagonize The Action Of Exogenous Insulin For Glycemic Control In Streptozocin-Induced Diabetic Rhesus Monkeys

Different effects of two dipeptidyl peptidase-4 inhibitors and glimepiride on β-cell function in a newly designed two-step hyperglycemic clamp.